Skip to main content
Equibles

BANK OF AMERICA CORP /DE/

Bank

Position in RNAC — Cartesian Therapeutics, Inc.

CIK 70858 CHARLOTTE, NC
Back to RNAC Full portfolio

Position in RNAC

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$881,782
+$66,390 QoQ
Shares Held
84,624
-25.2% QoQ
Ownership
0.280%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#20
of 95 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RNAC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. RNAC ranks #221 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,039,178 $1,509,650,884
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,291,053 $805,023,185
3 CYTK
Cytokinetics Inc
 4,635,709 $394,916,048
4 ARGX
Argenx SE
 400,234 $371,325,094
5 ALNY
Alnylam Pharmaceuticals, Inc.
 994,476 $299,367,107
6 JAZZ
Jazz Pharmaceuticals plc
 1,136,091 $273,763,844
7 TVTX
Travere Therapeutics, Inc.
 4,568,341 $259,527,450
8 RPRX
Royalty Pharma plc
 4,149,422 $232,658,090

All Filings in RNAC

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $881,782 84,624
2025-12-31 $815,392 113,092
2025-09-30 $143,784 14,069
2025-06-30 $144,763 13,933
2025-03-31 $78,829 5,981
2024-12-31 $209,367 11,690
2024-09-30 $122,027 7,570
2024-06-30 $141,963 5,256
2024-03-31 $23,462 36,096
2023-12-31 $132,198 191,870
2023-09-30 $92,417 87,187
2023-06-30 $74,089 66,151
2023-03-31 $135,893 97,765
2022-12-31 $55,573 49,180
2022-09-30 $130,932 79,837
2022-06-30 $80,436 61,402
2022-03-31 $115,404 93,825
2021-12-31 $463,985 142,327
2021-09-30 $63,854 15,350
2021-06-30 $47,266 11,308
2021-03-31 $418,484 92,483
2020-12-31 $84,475 27,880
2020-09-30 $92,314 37,224
2020-06-30 $188,581 66,402
2020-03-31 $303,373 125,881